🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to explore the efficacy and safety of CsA opht...
Status
Completed
Location
Ophthalmological Center of Zhongshan University
Start Date
2020-11-05
Trial ID
NCT04541888
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of CsA opht...
Status
Completed
Location
Ophthalmological Center of Zhongshan University
Start Date
2018-05-09
Trial ID
NCT03676335
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar...
Status
Completed
Location
Toyos Clinic
Start Date
2018-07-01
Trial ID
NCT03287635
Treatments Being Tested
This study is being conducted to investigate the safety, comfort, and toler...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2013-05-17
Trial ID
NCT01817582
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled, ...
Status
Recruiting
Location
Xiamen Eye Center of Xiamen University
Start Date
2025-04-03
Trial ID
NCT06766357
Treatments Being Tested
In this study, two treatments typically used for dry eye disease will be tr...
Status
Unknown
Location
Opto-Réseau Sherbrooke Est
Start Date
2024-04-25
Trial ID
NCT06392438
Treatments Being Tested
A pilot study to evaluate the impact of Lotemax® Gel (loteprednol etabonate...
Status
Withdrawn
Location
Cincinnati Eye Institute
Start Date
2014-01
Trial ID
NCT02028312
Treatments Being Tested
This is a phase III, multicenter, randomized, double-masked, Active-control...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-20
Trial ID
NCT06942793
Treatments Being Tested